XENE

XENE Operating Income Growth

-38.81%TTM

Period ending:

XENE TTM Operating Income YoY %%
XENE TTM Operating Income YoY %906.98%-1343.08%
2014-06-302026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

XENE operating income growth history

Year-over-year operating income growth rate. The available trailing twelve months (ttm) series contains 49 observations from Jun 30, 2014 to Jun 30, 2026.

Xenon Pharmaceuticals Inc Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
-38.8111%
-40.842%
-33.5742%
-33.3693%
-33.9317%
-30.7757%
-30.4802%
-25.4436%
-27.6091%
-39.3092%
-65.7496%
-84.085%
-111.2279%
-100.2727%
-63.4866%
-64.9572%
-44.0364%
-104.193%
-152.3657%
-123.7724%
-109.3164%
-0.596%
26.8993%
24.408%
34.8781%
6.8214%
-12.6342%
-5.3729%
-39.8237%
-29.4699%
-16.703%
-25.5019%
-11.9485%
-19.3767%
-31.2608%
-36.5607%
-85.6218%
-205.6294%
-460.2032%
-1,125.3348%
-300.8974%
-200.1579%
-139.8883%
-113.6898%
-29.768%
-12.6908%
14.3534%
111.9152%
689.2357%

Compare operating income growth

All XENE financial metrics · XENE stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.